Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prognosis and life expectancy in multiple sclerosis].

H Angstwurm1

  • 1Neurologischen Klinik, Universität München.

Versicherungsmedizin
|April 1, 1991
PubMed
Summary

Multiple sclerosis prognosis can be assessed by disability and disease progression. Despite a potential 10-15 year reduction in life expectancy for multiple sclerosis patients, life insurance options should be explored.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Organ donation in Germany: an interim report of an inquiry in Bavaria to determine the number of potential donors].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

[Re: W.F. Haupt, W. Hölling: Diagnosis of brain death: medical and legal aspects under the transplantation law of the German Republic Fortschr Neurol Psychiat 2002; 70: 583-590].

Fortschritte der Neurologie-Psychiatrie·2003
Same author

[Definition of death and references on brain death, partial brain death and heart death].

Der Internist·1999
Same author

[Brain death--a certain sign of death].

Diskussionsforum medizinische Ethik·1990
Same author

[Cervical transverse spinal cord injury caused by knife stab injury].

Der Unfallchirurg·1990
Same author

[Organization of organ donation].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·1988

Area of Science:

  • Neurology
  • Medical Prognostics

Context:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Assessing prognosis and life expectancy in MS patients is crucial for management and planning.

Purpose:

  • To evaluate the factors influencing prognosis and life expectancy in multiple sclerosis.
  • To determine the feasibility of life insurance for individuals with MS.

Summary:

  • Prognosis and life expectancy in multiple sclerosis can be determined through regular examinations of disability status, disease duration, and disease course.
  • It is estimated that life expectancy for MS patients is collectively reduced by 10 to 15 years.
  • The study suggests that securing life insurance for multiple sclerosis patients should be achievable.

Impact:

  • Provides insights into the long-term outlook for multiple sclerosis patients.
  • Highlights the potential for improved financial planning and life insurance accessibility for individuals with MS.
  • Informs healthcare providers and insurers about the life expectancy considerations in multiple sclerosis.

Related Experiment Videos